AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Debt to Equity Over TimeFair Value
Percentile Rank29
3Y CAGR+23.8%
5Y CAGR-6.4%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+23.8%/yr
vs -24.4%/yr prior
5Y CAGR
-6.4%/yr
Recent acceleration
Acceleration
+48.2pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
3 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.25 | +13.6% |
| 2024 | 0.22 | +13.1% |
| 2023 | 0.20 | +47.6% |
| 2022 | 0.13 | -45.2% |
| 2021 | 0.24 | -31.0% |
| 2020 | 0.35 | -29.6% |
| 2019 | 0.50 | +22.8% |
| 2018 | 0.41 | +13.8% |
| 2017 | 0.36 | -49.8% |
| 2016 | 0.71 | - |